M. Steven Piver
#135,480
Most Influential Person Now
M. Steven Piver's AcademicInfluence.com Rankings
M. Steven Piverphilosophy Degrees
Philosophy
#6806
World Rank
#9909
Historical Rank
Logic
#3912
World Rank
#5140
Historical Rank
Download Badge
Philosophy
Why Is M. Steven Piver Influential?
(Suggest an Edit or Addition)M. Steven Piver's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Five Classes of Extended Hysterectomy for Women With Cervical Cancer (1974) (785)
- Staging laparotomy in early ovarian cancer. (1983) (458)
- Prognostic Significance of Cervical Lesion Size and Pelvic Node Metastases in Cervical Carcinoma (1975) (366)
- Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry (1993) (310)
- Metastatic patterns in histologic variants of ovarian cancer. An autopsy study (1989) (216)
- The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. (1988) (160)
- Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations (2004) (154)
- Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma (1999) (150)
- Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. (1997) (148)
- Uterine endolymphatic stromal myosis: a collaborative study. (1984) (123)
- Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. (1999) (123)
- Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. (1983) (113)
- Regular use of analgesic drugs and ovarian cancer risk. (2001) (105)
- Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. (1999) (103)
- Familial ovarian cancer: A report of 658 families from the gilda radner familial ovarian cancer registry 1981–1991 (2010) (102)
- Epidemiology and etiology of ovarian cancer. (1991) (101)
- Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum‐based chemotherapy (1996) (100)
- Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. (1983) (94)
- A prospective trail comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma. (1979) (93)
- Adriamycin and bleomycin, alone and in combination, in gynecologic cancers (1973) (93)
- Laparoscopic surgery in obese women. (1999) (91)
- Epidemiologic Differences Between Women With Extraovarian Primary Peritoneal Carcinoma and Women With Epithelial Ovarian Cancer (1998) (91)
- Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. (1981) (88)
- Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer (2007) (88)
- The accuracy of lymphangiography in carcinoma of the uterine cervix. (1971) (85)
- Patterns of metastasis in uterine sarcoma. An autopsy study. (1989) (83)
- A prospective trial of postoperative vaginal radium/cesium for grade 1–2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial ivasion in surgical stage I endometrial adenocarcinoma (1990) (82)
- Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry (2004) (82)
- Paraaortic Lymph Node Evaluation in Stage I Endometrial Carcinoma (1982) (81)
- Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. (2000) (81)
- High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix (1977) (79)
- Ovarian carcinoma: A decade of progress (1984) (74)
- The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study (1986) (74)
- Peritoneal papillary carcinoma. (1988) (73)
- Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. (1995) (72)
- Survival after ovarian cancer induced intestinal obstruction. (1982) (71)
- Familial ovarian cancer. (1979) (70)
- Extraovarian primary peritoneal carcinoma. (1998) (70)
- Microinvasive carcinoma of the vulva. (1978) (70)
- Fallopian tube cancer: The roswell park experience (1990) (67)
- Medroxyprogesterone acetate (depo‐provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma (1980) (66)
- Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. (1999) (65)
- Hydroxyurea and radiation therapy in advanced cervical cancer. (1974) (62)
- Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. (2000) (61)
- Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study. (1999) (61)
- Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma (1990) (60)
- Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma. (1988) (59)
- Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. (1987) (58)
- First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study. (1999) (58)
- A case-control study of milk-drinking and ovarian cancer risk. (1990) (58)
- Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. (1977) (58)
- Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation. (1998) (57)
- Para‐aortic lymphadenectomy, aortic node biopsy, and aortic lymphangiography in staging patients with advanced cervical cancer (1973) (55)
- Tubal ligation and the risk of ovarian carcinoma. (1997) (54)
- Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas (1988) (54)
- Conservative therapy for melanoma of the vulva. (1988) (54)
- Second‐Look Laparoscopy Prior to Proposed Second‐Look Laparotomy (1980) (53)
- Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapy. (1975) (53)
- Characterization of human ovarian carcinomas in a SCID mouse model. (1999) (52)
- Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary. (1999) (52)
- Familial Ovarian Cancer Registry. (1984) (51)
- Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneum. (1999) (49)
- Etiology, biology, and epidemiology of ovarian cancer. (1994) (49)
- BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. (2003) (47)
- Prognostic significance of the extent of cervical involvement by endometrial cancer. (1991) (46)
- The inferior gluteal flap in the difficult vulvar and perineal reconstruction. (1997) (46)
- Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. (1990) (45)
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinoma (1994) (44)
- Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. (1999) (43)
- Intestinal perforation secondary to paclitaxel. (1995) (43)
- Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer (1987) (43)
- Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus. (1993) (42)
- Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. (1997) (42)
- Radical Hysterectomy and Pelvic Lymphadenectomy Versus Radiation Therapy for Small (≤3 cm) Stage IB Cervical Carcinoma (1988) (41)
- Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer. (1998) (41)
- Small cell carcinoma of the ovary: a rapidly lethal tumor occurring in the young. (1985) (41)
- Correlation of TP53 mutations and p53 expression in ovarian tumors. (1998) (39)
- Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract. (1982) (39)
- Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. (1997) (39)
- Paget's Disease of the Vulva A Clinicopathologic Study of Eight Cases (1975) (39)
- Prospective Trial of Cisplatin, Adriamycin, and Dacarbazine in Metastatic Mixed Mesodermal Sarcomas of the Uterus and Ovary (1991) (38)
- Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. (1997) (38)
- Doxorubicin hydrochloride (adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography (1985) (37)
- Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study. (1996) (37)
- Epithelioid Sarcoma of the Vulva (1972) (36)
- Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy. (1992) (35)
- Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer. (1996) (35)
- Impact on Progression‐Free Survival of Adjuvant Cyclophosphamide, Vincristine, Doxorubicin (Adriamycin), and Dacarbazine (CYVADIC) Chemotherapy for Stage I Uterine Sarcoma: A Prospective Trial (1995) (34)
- Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer. (1998) (33)
- Characteristics of familial ovarian cancer: a report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry. (1996) (32)
- Evaluation of survival after second‐line intraperitoneal cisplatin‐based chemotherapy for advanced ovarian cancer (1994) (31)
- Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina. (1978) (31)
- Galactoside-binding lectin in human tissues. (1987) (31)
- Expression of the p53 Induced Tumor Suppressor p21waf1/cip1 in Ovarian Carcinomas: Correlation with p53 and Ki‐67 Immunohistochemistry (1997) (31)
- Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. (1999) (30)
- Microsatellite instability in ovarian and other pelvic carcinomas. (2000) (30)
- High‐dose methotrexate with “rescue” plus cyclophosphamide as initial chemotherapy in ovarian adenocarcinoma. A randomized trial with observations on the influence of C parvum immunotherapy (1980) (29)
- Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma. (1986) (29)
- The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. (1996) (29)
- Squamous cell carcinoma arising in ovarian endometriosis. (1978) (29)
- Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma. (1995) (29)
- Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay (1990) (28)
- Effect of hydroxyurea on the radiation response of C3H mouse mammary tumors (1972) (28)
- Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. (2000) (28)
- Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer. (1998) (27)
- Treatment of ovarian cancer at the crossroads: 50 years after single-agent melphalan chemotherapy. (2006) (27)
- Stage III and IV squamous cell carcinoma of the vulva. (1986) (27)
- Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study. (1998) (27)
- Dysgerminoma of the ovary: radiation therapy for recurrence and metastases. (1976) (26)
- Laparoscopic management of women with a family history of ovarian cancer (1999) (25)
- Effects of IL-12 on human ovarian tumors engrafted into SCID mice. (1999) (25)
- Photodynamic therapy in gynecologic malignancies. (1989) (25)
- Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry. (2002) (24)
- Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation (1986) (24)
- Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer. (1998) (24)
- Ovarian cancer in children. (1986) (24)
- Chemotherapy in management of mixed mesodermal tumors of the ovary. (1980) (24)
- The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears. (1998) (23)
- Melphalan chemotherapy in advanced ovarian carcinoma. (1978) (23)
- p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. (1999) (23)
- Cervical implantation metastasis by endometrial adenocarcinoma (1991) (22)
- Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice. (2000) (22)
- Melanoma of the Vulva (1975) (22)
- Prophylactic Anticoagulation as a Possible Cause of Inguinal Lymphocyst After Radical Vulvectomy and Inguinal Lymphadenectomy (1983) (22)
- Rates and risks of ovarian cancer in subgroups of white women in the United States. (1995) (22)
- Reduction of mortality and morbidity associated with pelvic exenteration. (1975) (22)
- Complications related to indwelling caval catheters on a gynecologic oncology service. (1998) (21)
- Uterine Prolapse During Pregnancy (1968) (21)
- Plasminogen activator content of gynecological tumors and their metastases. (1987) (21)
- Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea. (1985) (21)
- Surgery in advanced epithelial ovarian cancer. (2001) (21)
- The value of lymphangiography in malignant disease of the uterine cervix. (1972) (20)
- Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma. (1982) (20)
- Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix. (1984) (20)
- Vulvar carcinoma with 0.5 mm of invasion and associated inguinal lymph node metastasis (1993) (19)
- Localisation of the breast‐ovarian cancer susceptibility gene (BRCAI) on 17q12–21 to an interval of ⩽IcM (1994) (19)
- Para-aortic lymph node irradiation for carcinoma of the uterine cervix using split course technique. (1975) (18)
- Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report. (1989) (18)
- Cyclophosphamide, Adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinoma. (1983) (18)
- cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer. (1987) (17)
- Radioactive Colloids in the Treatment of Stage I A Ovarian Cancer (1972) (17)
- Cystadenocarcinoma of the ovary in a 4‐Year‐Old. Benign transformation during therapy (1980) (17)
- A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma. (1992) (17)
- Primary Ovarian Dysgerminoma in a Patient with a Germline BRCA1 Mutation (2000) (16)
- Pelvic Lymphadenectomy in Women With Carcinoma of the Clitoris (1977) (16)
- Analysis of failed and complicated laparoscopy on a gynecologic oncology service. (1999) (16)
- Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. (1980) (16)
- Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream. (1979) (16)
- Elevated activities of blood group Le gene dependent alpha(1----3)-L-fucosyltransferase in human saliva of Lewis negative patients with epithelial ovarian cancer. (1986) (16)
- Thrombotic thrombocytopenic purpura during pregnancy (1968) (16)
- A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma (1993) (15)
- Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma. (1989) (15)
- The value of pre-therapy peritoneoscopy in localized ovarian cancer. (1977) (15)
- Role of prophylactic surgery for women with genetic predisposition to cancer. (1998) (15)
- cis-Dichlorodiammineplatinum(II) as third-line chemotherapy in advanced ovarian adenocarcinoma. (1978) (15)
- Combined radical surgery, radiation therapy and chemotherapy in infants with vulvovaginal embryonal rhabdomyosarcoma. (1973) (15)
- Role of prophylactic hysterectomy in patients at high risk for hereditary cancers. (2006) (15)
- Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. (1997) (14)
- Primary peritoneal adenocarcinoma metastatic to the brain. (1997) (14)
- The Safety of Multiple Cesarean Sections (1969) (14)
- A polymorphism in intron 2 of the TP53 gene. (2008) (14)
- BRCA1 mutations (2003) (13)
- Importance of lymph node metastases in primary peritoneal carcinoma (1998) (13)
- The twenty-first century role of Piver-Rutledge type III radical hysterectomy and FIGO stage IA, IB1, and IB2 cervical cancer in the era of robotic surgery: a personal perspective. (2010) (13)
- Adenocarcinoma in an Isolated Sigmoid Urinary Conduit (1984) (13)
- Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary. (1974) (13)
- Phase II Trial of Cisplatin, Adriamycin, and Etoposide for Metastatic Endometrial Adenocarcinoma (1991) (13)
- Invasive cervical cancer in the 1990s. (1990) (12)
- Lymphocyte response to autologous tumor antigen(S) and phytohemagglutinin in ovarian cancer patients (1975) (12)
- cis-Diamminedichloroplatinum plus dimethyl-triazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvis. (1986) (12)
- Change in International Federation of Gynecology and Obstetrics staging. (1988) (12)
- Conservative surgery plus adjuvant therapy for vulvovaginal rhabdomyosarcoma, diethylstilbestrol clear cell adenocarcinoma of the vagina, and unilateral germ cell tumors of the ovary. (1992) (12)
- Second-look laparotomy in advanced ovarian cancer: A critical assessment of morbidity and impact on survival (1997) (12)
- The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective study. (1986) (12)
- High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. (1977) (12)
- Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma. (1981) (11)
- Leo 1031 (NSC-134087) in gynecologic malignancies. (1978) (11)
- Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy. (1990) (11)
- Risk factors and current management in carcinoma of the endometrium. (1986) (11)
- Intraoperative Orthovoltage Radiation Therapy in the Treatment of Recurrent Gynecologic Malignancies (1993) (11)
- Ovarian malignancies : diagnostic and therapeutic advances (1987) (11)
- Galaptin and galaptin-binding glycoconjugates in serum and effusions of carcinoma patients. (1993) (10)
- Enterovaginal and Enterocutaneous Fistulae in Women With Gynecologic Malignancies (1976) (10)
- Optimal surgical therapy in stage I and II ovarian malignancies. (1982) (10)
- Ovarian malignancies: The clinical care of adults and adolescents (1983) (10)
- Weekly cis-diamminedichloroplatinum(II): active third-line chemotherapy in ovarian carcinoma--a preliminary report. (1980) (10)
- Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report. (1990) (10)
- Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes. (1984) (10)
- Cis‐diamminedichloroplatinum (II): Second line induction chemotherapy in advanced ovarian adenocarcinoma (1983) (9)
- Ovarian pregnancy and intrauterine device. (1967) (9)
- Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vagina. (1980) (9)
- Prophylactic oophorectomy: a century-long dilemma. (1997) (9)
- Stage III uterine sarcoma: case report and literature review. (1979) (9)
- FAMILIAL OVARIAN CANCER: INCREASING IN FREQUENCY? (1982) (8)
- Five‐year survival for cisplatin‐based chemotherapy versus single‐agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery (1991) (8)
- 1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer. (1987) (8)
- Para-aortic Lymphadenectomy in Staging Patients With Advanced Local Cervical Cancer (1974) (8)
- Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic. (1988) (8)
- Screening for the BRCA1‐ins6kbEx13 mutation: potential for misdiagnosis (2007) (8)
- The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer (2006) (8)
- An alternative splice site junction in exon 1a of the BRCA1 gene. (1998) (8)
- Incontinence of urine and stool following treatment in infancy for embryonal rhabdomyosarcoma. (1983) (8)
- Serum β-(1→4)-galactosyltransferase activity with synthetic low molecular weight acceptor in human ovarian cancer (1987) (8)
- Classification of IVS1-10T-->C as a polymorphism of BRCA1. (1999) (8)
- Radical hysterectomy and pelvic lymphadenectomy versus radiation therapy for small (less than or equal to 3 cm) stage IB cervical carcinoma. (1988) (8)
- Stage I adenocarcinoma of the cervix: does lesion size affect treatment options and prognosis? (1998) (7)
- Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report. (1979) (7)
- Primary resection of vaginal metastases with the Cavitron ultrasonic surgical aspirator in stage III endometrial carcinoma. (1990) (7)
- Microglandular hyperplasia of the endocervix following long-term estrogen treatment. (1977) (7)
- Cisplatin Plus VP16 213 in Refractory Ovarian Carcinoma (1987) (7)
- Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report. (1980) (7)
- Specialized surgery in ovarian cancer. (1987) (7)
- Galactorrhea and abnormal menses associated with a long-acting progesterone. (1967) (7)
- Serum α1-acid glycoprotein in epithelial ovarian cancer (1988) (6)
- Antigenic Studies on an Enzymatically Sialylated Carbohydrate: NeuAc(α2-3)Gal(β1-3)GalNAc (1991) (6)
- Childhood ovarian cancers. New advances in treatment. (1979) (6)
- Preoperative and Intraoperative Evaluation in Ovarian Malignancy (1976) (6)
- Serum alpha 1-acid glycoprotein in epithelial ovarian cancer. (1988) (6)
- Stage II invasive adenocarcinoma of the ovary: results of treatment by whole abdominal radiation plus pelvic boost versus pelvic radiation plus oral melphalan chemotherapy. (1986) (6)
- Assessment of Family Cancer History Collection and Utilization in Patient Care (1999) (6)
- Cystadenocarcinoma of the ovary in a 4-year-old: benign transformation during therapy. (1980) (6)
- Response to Taxol chemotherapy in resistant ovarian carcinoma. (1993) (5)
- The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: a personal perspective. (2008) (5)
- Progesterone therapy for malignant peritoneal cytology surgical stage I endometrial adenocarcinoma. (1988) (5)
- The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma. (1997) (5)
- Limitations of Drug Sensitivity Testing in Soft Agar for Clinical Management of Patients With Ovarian Carcinoma (1985) (5)
- Hypertension 6 weeks post partum in apparently normal women. A reappraisal and challenge. (1967) (5)
- Identical, unique p53 mutations in a primary ovarian mucinous adenocarcinoma and a synchronous contralateral ovarian mucinous tumor of low malignant potential suggest a common clonal origin. (1997) (5)
- The genetics of ovarian cancer. (1992) (5)
- Long-acting progesterone as a cause of missed abortion. (1967) (5)
- Comparison of cytosol estrogen receptor status in ovarian carcinoma using different radiolabeled ligands and methods (1982) (5)
- Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer (1993) (5)
- Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer. (1979) (5)
- LONG‐TERM FOLLOW‐UP AND COMPLICATIONS OF INFANTS WITH VULVOVAGINAL EMBRYONAL RHABDOMYOSARCOMA TREATED WITH SURGERY, RADIATION THERAPY, AND CHEMOTHERAPY (1988) (4)
- Distant metastasis of adenoacanthoma of the endometrium. (1966) (4)
- Primary fallopian tube cancer—The roswell park experience (1990) (4)
- Influence of Luteal Cysts on Menstrual Function (1970) (4)
- Melphalan, 5‐fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma (1987) (4)
- The intrauterine device: three years of clinical experience. (1968) (4)
- Advanced uterine sarcoma; response to chemotherapy. (1988) (4)
- 16,090: the 2004 estimated U.S. mortality from ovarian cancer. (2005) (4)
- Para-aortic lymph node metastasis in FIGO stage I endometrial carcinoma. Value of surgical staging and results of treatment. (1982) (4)
- Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park. (1992) (4)
- Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer. (1998) (4)
- Immunoscintigraphy Using 111InCyt103 Prior to Second Look Laparotomy in Ovarian Cancer: A Pilot Study (1994) (4)
- Treatment of cervical intraepithelial neoplasia. (1984) (4)
- Stage I endometrial carcinoma: the role of adjunctive radiation therapy. (1980) (3)
- Chemotherapy in ovarian carcinoma recurrent after radiation therapy. (1978) (3)
- The saf-t-coil, an IUD. (1968) (3)
- Epidemiologic Perspective of Ovarian Cancer (2009) (3)
- High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma. (1979) (3)
- Single Agent Vs Combination Chemotherapy in The Treatment of Ovarian Cancer (1977) (3)
- Antigenic studies on an enzymatically sialylated carbohydrate: NeuAc(alpha 2-3)Gal(beta 1-3)[GlcNAc(beta 1-6)]GalNAc. (1991) (3)
- Importance of proper staging in ovarian carcinoma. (1983) (3)
- The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma. (1993) (3)
- Effective Management of Pelvic Lymphocysts by Laparoscopic Marsupialfeation (1999) (3)
- Patient-controlled analgesia in gynecologic oncology. A comparative analysis. (1989) (3)
- Radiation associated hyperthyroidism in patients with gynecological malignancies. (1987) (2)
- Is there a role for adjuvant chemotherapy in cervical cancer? (1985) (2)
- Synthesis and release of glycoconjugates bearing N-linked oligosaccharides by ovarian carcinoma cells isolated from effusions. (1989) (2)
- Feasibility of Postpartum Insertion of IUCD (1966) (2)
- Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a case report. (1989) (2)
- Prospective trial of optimal cytoreductive surgery in advanced ovarian carcinoma (1986) (2)
- Standard administration of hydroxyurea recommended. (1989) (2)
- Testicular Feminization: A Study of Two Families (1966) (2)
- Potential for cure in ovarian cancer. (1986) (2)
- Maintenance chemotherapy in advanced ovarian cancer. (2000) (2)
- Malignant peritoneal cytology in stage I endometrial adenocarcinoma: the effect of progesterone therapy (a preliminary report). (1988) (2)
- The value of pretherapy para-aortic lymphadenectomy for carcinoma of the cervix uteri. (1977) (2)
- Monilia Septicemia Associated with Hyperalimentation (1971) (2)
- Hydroxyurea and radiation therapy in the treatment of carcinoma of the cervix (1987) (1)
- 5. Five‐Year Survival in Non‐Surgically Staged Negative Lymphangiogram Stage IIB Carcinoma of the Cervix Treated by Pelvic Radiation (RT) Plus Hydroxyurea (1985) (1)
- 5 Year survival rate (NED) in patients with biopsy confirmed aortic node metastasis from cervical carcinoma (1980) (1)
- Systematic surgical staging: stage I ovarian cancer. (1997) (1)
- Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial ovarian cancer: results of a phase II trial. (1994) (1)
- Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer. (1976) (1)
- High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma. (1975) (1)
- Significantly improved 5-year survival in women with stage IIB cervical cancer treated with hydroxyurea plus radiation as compared to placebo plus radiation (1983) (1)
- Short Report on DNA Marker at Candidate Locus (1996) (1)
- The Gilda Radner Familial Ovarian Cancer Registry 1981-2000. (2000) (1)
- BRCA 1 / 2 Mutation Status Influences Somatic Genetic Progression in Inherited and Sporadic Epithelial Ovarian Cancer Cases 1 (2003) (1)
- Delayed hypersensitivity reactions vs chemotherapy and immunotherapy responses in women with ovarian adenocarcinoma (1981) (1)
- Cervical cancer in the adolescent patient. (1986) (1)
- An extremely elevated serum CA125 level in a Crohn's patient developing endometriosis and the establishment of a cell line (MD-E) from the endometrioma. (1991) (1)
- Effect of an Intrauterine Contraceptive Device upon Cervical and Endometrial Exfoliative Cytology (1966) (1)
- Intrauterine contraceptive device and ovarian thecoma. (1966) (1)
- Synthesis and release of cell surface-derived and sulfated lactosaminoglycans by human ovarian carcinoma cells. (1991) (1)
- Hormone Replacement Therapy as a Risk Factor for Epithelial Ovarian Cancer: Results of a Case‐Cntrol Study (1997) (1)
- 21st century challenge of ovarian cancer in the elderly. A personal perspective. (2008) (1)
- Pathology of malignant ovarian tumors. (1990) (1)
- Management of early ovarian cancer. (2004) (1)
- Characterization of glycoconjugates released in vitro by human ovarian carcinoma cells isolated from effusions. (1991) (0)
- Comparison of cytosol estrogen receptor status in ovarian carcinoma using different radiolabeled ligands and methods. (1983) (0)
- Comparison of Ifosfamide versus cyclophosphamide in combination with Cisplatin and Doxorubicin (adriamycin), as first-line therapy for advanced epithelial ovarian-cancer - report of a pilot-study. (1994) (0)
- Ultraradical Surgery in Advanced Carcinoma of the Ovary (1986) (0)
- Treatment of high-risk cervical cancer. (1999) (0)
- Treatment of metastatic lipid cell tumor of the ovary with BV-CAP and VAC chemotherapy, using serum testosterone and dihydrotestosterone as tumor markers. (1988) (0)
- PRO: Prophylactic Oophorectomy and Ovarian Cancer (1995) (0)
- Insurance policies for prophylactic mastectomy: to cover or not to cover? (2000) (0)
- Commentary (Piver): Management of Ovarian Cancer (2006) (0)
- Effect of Methanesulfonamide on Uterine Contractions (1966) (0)
- CHAPTER 17 – Epidemiology of Ovarian Cancer (2003) (0)
- Metastatic gestational trophoblastic disease: secondary chemotherapy. (1980) (0)
- Synthesis and release of glycoconjugates in vitro by human ovarian carcinoma cells isolated from effusions. (1989) (0)
- Slow progress in the treatment of para-aortic lymph node metastasis from clinical stage I endometrial adenocarcinoma. (1993) (0)
- "Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma". (1986) (0)
- Split thickness skin graft reconstruction following radical vulvectomy and/or radical excision of the perineum (1989) (0)
- Breast-cancer genomics. (2003) (0)
- Epidemiologic differences between women with colorectal cancer and women with ovarian cancer (2001) (0)
- Clinically localized ovarian cancer. Progress in management. (1985) (0)
- Invasive carcinoma of uterine cervix. Diagnostic and therapeutic changes. (1975) (0)
- Letter to the Editor (2000) (0)
- Cytoreductive surgery in gynecologic malignancies. (1983) (0)
- Survival after Ovarian Cancer-induced Intestinal Obstruction (1982) (0)
- Neoplasms (1989) (0)
- Fetal outcome in nondiabetic glucosuria in pregnancy. (1967) (0)
- Tumor-infiltrating lymphocytes: in vitro characterization of morphological and phenotypical changes. (1988) (0)
- Contents Vol. 1, 1998 (1999) (0)
- Stage I carcinoma of the endometriumSurgical staging and treatment (1989) (0)
- Antigenic studies on an enzymatically sialylated carbohydrate: NeuAc(alpha 2-3)Gal(beta 1-3)GalNAc. (1991) (0)
- Prevention of infection and wound breakdown with split thickness skin graft reconstruction following radical vulvectomy (1990) (0)
- On Steve Jobs (2012) (0)
- Lymphangiography in Carcinoma of the Cervix (1971) (0)
- One-Hour Intravenous Glucose Tolerance Test: An Accurate Screening Test for Diabetes During Pregnancy (1968) (0)
- Are you missing gynaecological cancers at the early stage? (1978) (0)
- Continued controversies in the diagnosis and treatment of ovarian adenocarcinomas. (1979) (0)
- Serum beta-(1----4)-galactosyltransferase activity with synthetic low molecular weight acceptor in human ovarian cancer. (1987) (0)
- Authors should not compare survival of responders and nonresponders without discussing the limitations of such a comparison. (1987) (0)
- Commentary (Piver): Management of Intestinal Obstruction in the Patient With Ovarian Cancer (2000) (0)
- Response to Chudina et al. (1985) (0)
- Recent advances in gynecologic malignancies. (1990) (0)
- Advances in the Treatment of Gynecologic Malignancies (2017) (0)
- A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-based chemotherapy for recurrent epithelial ovarian cancer. (2001) (0)
- Guidelines for the management of patients with ovarian adenocarcinoma. (1972) (0)
- Clinical evaluation of hypertension six weeks postpartum. (1969) (0)
- Pre-therapy para-aortic lymphadenectomy in locally advanced carcinoma of the uterine cervix (1977) (0)
- Prophylactic oophorectomy: a century long dilemma : Prophylactic oophorectomy (1997) (0)
- Subject Index Vol. 1, 1998 (1999) (0)
- Serial CA 125 levels during chemotherapy for metastatic or recurrent endométrial cancer (1992) (0)
- Familial Ovarian Cancer Registry Report (1985) (0)
- The use of lymphadenectomy in clinical stage I endometrial adenocarcinoma at a large community hospital. (2001) (0)
- Simple removal of cerclage suture for incompetent cervix. (1969) (0)
- Six-month interval laparoscopy to evaluate response to chemotherapy in advanced ovarian carcinoma (1986) (0)
- Cisplatin-based chemotherapy for metastatic endometrial adenocarcinoma: Possible added effects of etoposide (1990) (0)
This paper list is powered by the following services:
